Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2025-12-30 @ 1:21 PM
Study NCT ID:
NCT00127933
Status:
COMPLETED
Last Update Posted:
2011-08-10
First Post:
2005-08-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ML18530
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Disclosures Group
Old Organization:
Hoffmann-La Roche